Similar to our study on KLF4, it has been shown that splicing deregulation of KLF6 results in a specific variant, KLF6-v1, that is associated with an increased risk of various cancers and opposes KLF6(FL) effects [31–37]. The gene discussed is KLF4; the disease is cancer.